We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.3B
AUM Growth
+$177M
Cap. Flow
+$235M
Cap. Flow %
18.05%
Top 10 Hldgs %
40.67%
Holding
213
New
103
Increased
34
Reduced
21
Closed
43

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$47.9M
2
ABBV icon
AbbVie
ABBV
+$27.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$18.7M
4
LPSN icon
LivePerson
LPSN
+$16.1M
5
AZN icon
AstraZeneca
AZN
+$13.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$40.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$26.4M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$12.8M
4
ZYME icon
Zymeworks
ZYME
+$11.6M
5
META icon
Meta Platforms (Facebook)
META
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 62.55%
2 Technology 7.69%
3 Industrials 4.91%
4 Financials 2.93%
5 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLHAU
151
DELISTED
Glass Houses Acquisition Corp. Unit
GLHAU
$902K 0.07%
+89,884
New +$898K
NVMI
152
Nova
NVMI
$12.4B
$779K 0.06%
8,556
-69,557
-89% -$5.61M
LOKM.U
153
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$749K 0.06%
+75,000
New +$764K
CEREW
154
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$702K 0.05%
166,332
– –
LABP
155
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$674K 0.05%
+7,000
New +$913K
SUNL
156
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$523K 0.04%
+2,500
New +$585K
VTIQU
157
DELISTED
VectoIQ Acquisition Corp. II Unit
VTIQU
$507K 0.04%
+50,000
New +$549K
SCAQU
158
DELISTED
Stratim Cloud Acquisition Corp. Unit
SCAQU
$500K 0.04%
+50,000
New +$500K
ZWRKU
159
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
$498K 0.04%
+50,000
New +$517K
EJFAU
160
DELISTED
EJF Acquisition Corp. Unit
EJFAU
$497K 0.04%
+49,900
New +$499K
AGGRU
161
DELISTED
Agile Growth Corp Units
AGGRU
$496K 0.04%
+50,000
New +$496K
MDH.U
162
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
$308K 0.02%
+31,000
New +$314K
WGS icon
163
GeneDx Holdings
WGS
$1.93B
$298K 0.02%
+606
New +$315K
IMTXW
164
DELISTED
Immatics N.V. Warrants
IMTXW
$295K 0.02%
100,000
– –
NRACU
165
DELISTED
Northern Revival Acquisition Corporation Unit
NRACU
$277K 0.02%
+28,000
New +$284K
FTEV.U
166
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$247K 0.02%
+25,000
New +$250K
SRSA
167
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$242K 0.02%
+23,900
New +$252K
NBSE
168
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$236K 0.02%
+1,595
New +$289K
OTLKW
169
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$131K 0.01%
129,500
– –
ABBV icon
170
CALL
AbbVie
ABBV
$443B
– –
-225,000
Closed -$24.1M
ACRS icon
171
Aclaris Therapeutics
ACRS
$726M
– –
-150,000
Closed -$971K
ALGS icon
172
Aligos Therapeutics
ALGS
$26.2M
– –
-2,960
Closed -$2.05M
ASND icon
173
Ascendis Pharma A/S
ASND
$16B
– –
-23,599
Closed -$3.94M
LONA
174
LeonaBio Inc
LONA
$66.3M
– –
-5,390
Closed -$1.85M
BCAB icon
175
BioAtla
BCAB
$5.46M
– –
-1,000
Closed -$1.7M
5 6
7
8 9

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sphera Funds Management held 213 positions worth $1.3B, up 16% from $1.13B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sphera Funds Management deployed $235M of net new capital in Q1 2021, opening 103 new positions and adding to 34 existing holdings. Its largest new stake was Sanofi: 997,900 shares worth $49.4M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 68% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $26.4M trimmed.

  • Sphera Funds Management's largest Q1 2021 buy was Sanofi: 997,900 shares worth $49.4M.
  • Sphera Funds Management added most to AbbVie in Q1 2021, an estimated $27.8M increase.
  • Sphera Funds Management's biggest Q1 2021 reduction was Bristol-Myers Squibb, cutting an estimated $26.4M.
  • Sphera Funds Management fully exited Novartis in Q1 2021, selling an estimated $40.5M.
  • Sphera Funds Management's ten largest holdings make up 41% of its $1.3B portfolio in Q1 2021.
  • Sphera Funds Management opened 103 new positions and closed 43 in Q1 2021.
  • Sphera Funds Management's portfolio value rose 16% quarter-over-quarter to $1.3B.

Based on Sphera Funds Management's 13F filing for Q1 2021, filed 17 May 2021.